Washington Trust Advisors’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-45
Closed -$3.24K – 688
2023
Q1
$3.24K Hold
45
– – ﹤0.01% 678
2022
Q4
$3.36K Hold
45
– – ﹤0.01% 660
2022
Q3
$3K Buy
45
+6
+15% +$459 ﹤0.01% 788
2022
Q2
$3K Hold
39
– – ﹤0.01% 816
2022
Q1
$4K Hold
39
– – ﹤0.01% 848
2021
Q4
$4K Buy
+39
New +$3.98K ﹤0.01% 876

Other funds holding CRI

Washington Trust Advisors's CRI Position: Q2 2023 in Review

Washington Trust Advisors sold out of Carter's (CRI) in Q2 2023, closing a stake of 45 shares — an estimated $3.24K sold.

Washington Trust Advisors first reported a position in CRI in Q4 2021 and held it in 6 quarters. The position peaked at $4K in Q1 2022. 291 funds tracked by Wall St. Rank hold CRI as of Q2 2023.

  • Washington Trust Advisors reported no remaining Carter's position as of Q2 2023 after selling out during the quarter.
  • Washington Trust Advisors sold 45 Carter's shares in Q2 2023, an estimated $3.24K.
  • Washington Trust Advisors first reported a position in Carter's in Q4 2021 and held it in 6 quarters.
  • Washington Trust Advisors's Carter's position peaked at $4K in Q1 2022.
  • 291 funds tracked by Wall St. Rank held Carter's as of Q2 2023.

Based on Washington Trust Advisors's 13F filing for Q2 2023, filed 27 Jul 2023.